Search Within

Gaurav D Shah

Formats
  1. Journal Article (8)
  2. Meeting Abstract (4)
Groups
  1. Survivorship Research (6)
  2. Tow Center for Developmental Oncology (TCDO) (5)
  3. Biostatistics Service (4)
  4. Epidemiology and Biostatistics (4)
  5. Population Sciences Research Program (4)
  6. Radiation Oncology, Department of (4)

More Groups

People
  1. Lauren Abrey (8)
  2. Lisa De Angelis (5)
  3. Denise Correa (4)
  4. Joachim Yahalom (4)
  5. Katherine Panageas (4)
  6. Andrew Lassman (3)

More People

Years
  1. 2013 (1)
  2. 2010 (1)
  3. 2008 (1)
  4. 2007 (4)
  5. 2006 (3)
  6. 2005 (2)
Publications
  1. Journal of Clinical Oncology (3)
  2. Journal of Neuro-Oncology (2)
  3. Neuro-Oncology (2)
  4. Annals of Oncology (1)
  5. Cancer Treatment and Research (1)
  6. Hematology/Oncology Clinics of North America (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (3)
  2. Oxford University Press (3)
  3. Springer (3)
  4. Elsevier Inc. (2)
  5. Lippincott Williams & Wilkins (1)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome
    Journal Article

    Morris, P. G.; Correa, D. D.; Yahalom, J.; Raizer, J. J.; Schiff, D.; Grant, B.; Grimm, S.; Lai, R. K.; Reiner, A. S.; Panageas, K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant temozolomide in resectable melanoma patients
    Journal Article

    Shah, G. D.; Socci, N. D.; Gold, J. S.; Wolchok, J. D.; Carvajal, R. D.; Panageas, K. S.; Viale, A.; Brady, M. S.; Coit, D. G.; Chapman, P. B.
    Annals of Oncology (2010)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant temozolomide in advanced melanoma
    Meeting Abstract

    Shah, G. D.; Coit, D. G.; Brady, M.; Wolchok, J. D.; Carvajal, R. D.; Busam, K.; Panageas, K.; Roman, R.; Viale, A.; Socci, N.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma
    Journal Article

    Shah, G. D.; Yahalom, J.; Correa, D. D.; Lai, R. K.; Raizer, J. J.; Schiff, D.; LaRocca, R.; Grant, B.; Deangelis, L. M.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas
    Journal Article

    Shah, G. D.; Silver, J. S.; Rosenfeld, S. S.; Gavrilovic, I. T.; Abrey, L. E.; Lassman, A. B.
    Journal of Neuro-Oncology (2007)

    Fulltext@MSK | Save
  • Adjuvant therapy of melanoma
    Journal Article

    Shah, G. D.; Chapman, P. B.
    The Cancer Journal (2007)

    Fulltext@MSK | Save
  • Chemotherapy for brain metastases: Breast, gynecologic and non-melanoma skin malignancies
    Journal Article

    Shah, G. D.; Abrey, L. E.
    Cancer Treatment and Research (2007)

    Fulltext@MSK | Save
  • Reduced-dose whole brain radiotherapy (WBRT) following complete response to immuno-chemotherapy in patients with primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Yahalom, J.; Shah, G. D.; Lai, R. K.; Correa, D. D.; Deangelis, L. M.; Abrey, L. E.
    International Journal of Radiation Oncology, Biology, Physics (2006)

    Fulltext@MSK | Save
  • Severe and persistent myelosuppression in a patient responding to concurrent imatinib with hydroxyurea for recurrent GBM
    Meeting Abstract

    Shah, G. D.; Silver, J. S.; Gavrilovic, I.; Abrey, L. E.; Lassman, A. B.
    Neuro-Oncology (2006)

    Fulltext@MSK | Save
  • Systemic high-dose intravenous methotrexate for central nervous system metastases
    Journal Article

    Lassman, A. B.; Abrey, L. E.; Shah, G. D.; Panageas, K. S.; Begemann, M.; Malkin, M. G.; Raizer, J. J.
    Journal of Neuro-Oncology (2006)

    Fulltext@MSK | Save